NEW YORK (CNNMoney.com) -- Tercica, a California-based biotechnology company, announced a deal with Genentech Tuesday ... (down $0.01 to $0.79, Charts), based in Richmond, Va., ...

The San Francisco company, which this summer added a handful of Genentech alumni, including former CEO Ian Clark, started a clinical trial in August for its experimental metastatic breast cancer drug.

Biotech leader Genentech built its plant in Vacaville in 1997. Company officials including development facilitator Joaquin Castaneda failed to respond to requests for comment from the Business ...

Genentech’s commitment to diversity and inclusion is also on display in the company's organizational chart, Highsmith said. “While diversity teams are typically housed under the human ...